See more : Österreichische Post AG (POST.VI) Income Statement Analysis – Financial Results
Complete financial analysis of Moolec Science SA (MLECW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Moolec Science SA, a leading company in the Biotechnology industry within the Healthcare sector.
- Hudson Resources Inc. (HUD.V) Income Statement Analysis – Financial Results
- Hainan Manaslu Acquisition Corp. (HMAC) Income Statement Analysis – Financial Results
- Senvest Capital Inc. (SEC.TO) Income Statement Analysis – Financial Results
- CJ CGV Co., Ltd. (079160.KS) Income Statement Analysis – Financial Results
- IDEX Biometrics ASA (0MTP.L) Income Statement Analysis – Financial Results
Moolec Science SA (MLECW)
About Moolec Science SA
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 5.63M | 905.05K | 0.00 | 0.00 |
| Cost of Revenue | 5.15M | 1.05M | 0.00 | 0.00 |
| Gross Profit | 472.58K | -143.31K | 0.00 | 0.00 |
| Gross Profit Ratio | 8.40% | -15.83% | 0.00% | 0.00% |
| Research & Development | 1.77M | 1.35M | 985.16K | 0.00 |
| General & Administrative | 6.54M | 47.42M | 2.52M | 0.00 |
| Selling & Marketing | 643.06K | 256.42K | 105.06K | 0.00 |
| SG&A | 7.18M | 47.67M | 2.63M | 13.80K |
| Other Expenses | 564.22K | -42.51M | 0.00 | 0.00 |
| Operating Expenses | 9.52M | 6.51M | 3.65M | 13.80K |
| Cost & Expenses | 14.67M | 7.47M | 3.65M | 13.80K |
| Interest Income | 1.39M | 693.03K | 13.32K | 0.00 |
| Interest Expense | 1.17M | 160.04K | 2.13K | 0.00 |
| Depreciation & Amortization | 1.01M | 122.02K | 1.70K | 206.30K |
| EBITDA | -6.16M | -51.74M | -3.65M | -13.80K |
| EBITDA Ratio | -109.50% | -5,716.97% | 0.00% | 0.00% |
| Operating Income | -9.04M | -6.65M | -3.65M | -13.80K |
| Operating Income Ratio | -160.76% | -735.19% | 0.00% | 0.00% |
| Total Other Income/Expenses | 683.61K | -45.37M | -872.34K | -2.00 |
| Income Before Tax | -8.36M | -52.02M | -4.53M | -13.80K |
| Income Before Tax Ratio | -148.61% | -5,748.13% | 0.00% | 0.00% |
| Income Tax Expense | -1.05M | -234.54K | 2.13K | -206.30K |
| Net Income | -7.31M | -51.79M | -4.53M | -13.80K |
| Net Income Ratio | -129.99% | -5,722.22% | 0.00% | 0.00% |
| EPS | 0.00 | -1.50 | -0.26 | 0.00 |
| EPS Diluted | 0.00 | -1.50 | -0.26 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 34.47M | 17.37M | 17.37M |
| Weighted Avg Shares Out (Dil) | 0.00 | 34.47M | 17.37M | 17.37M |
Moolec Science (MLEC) Q4 2024 Earnings Call Transcript
Why Is Moolec Science (MLEC) Stock Up 121% Today?
Why Is Moolec Science (MLEC) Stock Up 40% Today?
Moolec Science SA (MLEC) Q1 2024 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports